These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34360679)

  • 21. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
    Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.
    Yamada Y; Arai T; Kojima S; Sugawara S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2018 Sep; 109(9):2919-2936. PubMed ID: 29968393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Slaby O; Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R
    Genes Chromosomes Cancer; 2012 Jul; 51(7):707-16. PubMed ID: 22492545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
    Liu S; Deng X; Zhang J
    Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.
    Butz H; Nofech-Mozes R; Ding Q; Khella HWZ; Szabó PM; Jewett M; Finelli A; Lee J; Ordon M; Stewart R; Krylov S; Yousef GM
    Eur Urol Focus; 2016 Jun; 2(2):210-218. PubMed ID: 28723537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated analysis identifies microRNA-188-5p as a suppressor of AKT/mTOR pathway in renal cancer.
    Shen H; Jin J; Wang H; Yu N; Liu T; Sheng H; Wan Z; Feng C; Huang Y; Gao F
    Cancer Sci; 2023 Aug; 114(8):3128-3143. PubMed ID: 37199297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the Urinary Exosome microRNA Profile of von Hippel Lindau Syndrome Patients with Clear Cell Renal Cell Carcinoma.
    Walter-Rodriguez B; Ricketts CJ; Linehan WM; Merino MJ
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma.
    Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L
    Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma.
    Li R; Lu C; Li X; Chen X; Huang G; Wen Z; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Lai Y
    Front Genet; 2022; 13():897827. PubMed ID: 35938021
    [No Abstract]   [Full Text] [Related]  

  • 37. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
    Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
    Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity.
    Belmonte T; Perez-Pons M; Benítez ID; Molinero M; García-Hidalgo MC; Rodríguez-Muñoz C; Gort-Paniello C; Moncusí-Moix A; Madè A; Devaux Y; Martelli F; Ortega A; González J; Torres G; Barbé F; de Gonzalo-Calvo D
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):131926. PubMed ID: 38688344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.
    Friedrich M; Heimer N; Stoehr C; Steven A; Wach S; Taubert H; Hartmann A; Seliger B
    Sci Rep; 2020 Apr; 10(1):6499. PubMed ID: 32300145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.